Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 12,525 | 12,500 | 12,365 | 12,929 | 0 |
| Gross Profit | 12,525 | 12,500 | 12,365 | 12,929 | N/A |
| Operating Expenses | 13,086 | 12,016 | 13,586 | 11,965 | 0 |
| Operating Income | -561 | 484 | -1,221 | 964 | N/A |
| Other Income | 7 | 9 | 8 | 8 | 0 |
| Pre-tax Income | -554 | 493 | -1,213 | 972 | 0 |
| Income Tax | 1,192 | -140 | 482 | -386 | N/A |
| Net Income Continuous | -1,746 | 633 | -1,695 | 1,358 | N/A |
| Net Income | $-1,746 | $633 | $-1,695 | $1,358 | $N/A |
| EPS Basic Total Ops | -0.10 | 0.04 | -0.11 | 0.08 | N/A |
| EPS Basic Continuous Ops | -0.11 | 0.04 | -0.11 | 0.09 | N/A |
| EPS Diluted Total Ops | -0.10 | 0.04 | -0.11 | 0.08 | N/A |
| EPS Diluted Continuous Ops | -0.11 | 0.04 | -0.11 | 0.08 | N/A |
| EBITDA(a) | $-290 | $970 | $-692 | $1,497 | $N/A |